CN103154013B - 三糖衍生物以及它们作为佐剂的用途 - Google Patents

三糖衍生物以及它们作为佐剂的用途 Download PDF

Info

Publication number
CN103154013B
CN103154013B CN201180034937.5A CN201180034937A CN103154013B CN 103154013 B CN103154013 B CN 103154013B CN 201180034937 A CN201180034937 A CN 201180034937A CN 103154013 B CN103154013 B CN 103154013B
Authority
CN
China
Prior art keywords
trisaccharide
ester
fatty acid
chain
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180034937.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN103154013A (zh
Inventor
J·G·M·M·范步瑞
E·J·P·M·斯克拉斯
J·A·特克斯特拉
M·A·J·克里克
R·P·霍夫
W·M·M·斯哈佩尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunovo BV
Original Assignee
Immunovo BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovo BV filed Critical Immunovo BV
Publication of CN103154013A publication Critical patent/CN103154013A/zh
Application granted granted Critical
Publication of CN103154013B publication Critical patent/CN103154013B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
CN201180034937.5A 2010-06-11 2011-06-03 三糖衍生物以及它们作为佐剂的用途 Expired - Fee Related CN103154013B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10165707.0 2010-06-11
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (2)

Publication Number Publication Date
CN103154013A CN103154013A (zh) 2013-06-12
CN103154013B true CN103154013B (zh) 2017-03-15

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180034937.5A Expired - Fee Related CN103154013B (zh) 2010-06-11 2011-06-03 三糖衍生物以及它们作为佐剂的用途

Country Status (25)

Country Link
US (2) US9327020B2 (enExample)
EP (3) EP2397484A1 (enExample)
JP (2) JP6004586B2 (enExample)
KR (1) KR101929973B1 (enExample)
CN (1) CN103154013B (enExample)
AU (1) AU2011262606B2 (enExample)
BR (1) BR112012031440A2 (enExample)
CA (1) CA2802023C (enExample)
CY (1) CY1119704T1 (enExample)
DK (1) DK2580226T3 (enExample)
ES (1) ES2654156T3 (enExample)
HR (1) HRP20171947T1 (enExample)
HU (1) HUE035187T2 (enExample)
IL (1) IL223570A (enExample)
LT (1) LT2580226T (enExample)
MX (1) MX342946B (enExample)
NO (1) NO2580226T3 (enExample)
PL (1) PL2580226T3 (enExample)
PT (1) PT2580226T (enExample)
RS (1) RS56690B1 (enExample)
RU (1) RU2595717C2 (enExample)
SI (1) SI2580226T1 (enExample)
SM (1) SMT201700603T1 (enExample)
WO (1) WO2011155822A1 (enExample)
ZA (1) ZA201209395B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
NZ728551A (en) * 2014-07-24 2023-02-24 Litevax B V Sulphated carbohydrate fatty acid esters as vaccine adjuvants
KR20250052985A (ko) 2023-10-11 2025-04-21 세종대학교산학협력단 삼당류의 제조방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1433423A (zh) * 1999-11-30 2003-07-30 科瓦奇娜公司 单糖和二糖衍生物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
FI970867A7 (fi) * 1994-08-04 1997-04-08 Quadrant Drug Delivery Ltd Kiinteät, annostelusysteemit hallittua vapautumista varten, joihin sys teemeihin molekyylit on sisällytetty ja menetelmät niiden valmistamise ksi
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6517860B1 (en) * 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
EP1792607B1 (en) * 2005-12-01 2008-10-01 Wella Aktiengesellschaft Use of di- or oligosaccharide polyester in hair styling products
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
US9242010B2 (en) * 2008-05-16 2016-01-26 Research Foundation Of The City University Of New York Living copolymer-protein/peptide hybrids for biomedical applications
WO2010087207A1 (ja) * 2009-02-02 2010-08-05 大塚化学株式会社 低分子量多硫酸化ヒアルロン酸誘導体及びこれを含有する医薬
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1433423A (zh) * 1999-11-30 2003-07-30 科瓦奇娜公司 单糖和二糖衍生物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《Chemoenzymatic Syntheses of iGb3 and Gb3》;Qingjia Yao，et al;《Org.Lett》;20060531;第8卷(第5期);914页scheme3，右栏第二段1-3行 *

Also Published As

Publication number Publication date
CN103154013A (zh) 2013-06-12
US20130273082A1 (en) 2013-10-17
ES2654156T3 (es) 2018-02-12
EP2397484A1 (en) 2011-12-21
MX2012014422A (es) 2013-08-27
RU2013100945A (ru) 2014-07-20
ZA201209395B (en) 2014-05-28
PT2580226T (pt) 2018-01-05
EP2580226A1 (en) 2013-04-17
IL223570A (en) 2017-03-30
KR101929973B1 (ko) 2018-12-18
HUE035187T2 (hu) 2018-05-02
HRP20171947T1 (hr) 2018-02-23
AU2011262606A1 (en) 2013-01-10
SI2580226T1 (en) 2018-04-30
CY1119704T1 (el) 2018-06-27
MX342946B (es) 2016-10-18
CA2802023A1 (en) 2011-12-15
DK2580226T3 (en) 2018-01-08
JP2016216471A (ja) 2016-12-22
JP2013528211A (ja) 2013-07-08
RU2595717C2 (ru) 2016-08-27
KR20130056273A (ko) 2013-05-29
RS56690B1 (sr) 2018-03-30
PL2580226T3 (pl) 2018-05-30
AU2011262606B2 (en) 2016-10-27
US9327020B2 (en) 2016-05-03
WO2011155822A1 (en) 2011-12-15
EP3312188A1 (en) 2018-04-25
CA2802023C (en) 2020-07-14
NO2580226T3 (enExample) 2018-04-28
US20170057987A1 (en) 2017-03-02
LT2580226T (lt) 2018-02-26
JP6004586B2 (ja) 2016-10-12
SMT201700603T1 (it) 2018-03-08
BR112012031440A2 (pt) 2017-04-18
EP2580226B1 (en) 2017-11-29

Similar Documents

Publication Publication Date Title
US8052981B2 (en) Mono- and disaccharide derivatives
PT988862E (pt) Formulação compreendendo um antigénio, um adjuvante indutor de th-1 e um aminoácido pouco solúvel em água, para utilização em imunização
CN103154013B (zh) 三糖衍生物以及它们作为佐剂的用途
AU2015294769B2 (en) Adjuvants
RU2712750C1 (ru) Амилоидный конъюгат, его применения и способы
BR112018016016B1 (pt) Composição farmacêutica compreendendo um conjugado de um ou mais peptídeos cysab (33-40) (seq id no: 1) ligado à hemocianina do molusco keyhole limpet (klh), seu uso, seu método de produção, e ampola de vidro

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170315

Termination date: 20210603